A Randomized Trial for Suicidal Patients
"Collaborative Assessment and Management of Suicidality" (CAMS) in Comparison to "Treatment as Usual" (TAU) for Suicidal Patients: a Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Although suicide risk is highly prevalent among the patient population in mental health care, remarkably little research exists on effective treatments. Among a small set of novel approaches, CAMS is particularly promising. The investigators compare CAMS to TAU in a randomized controlled trial at four departments in Vestre Viken Hospital Trust, hypothesizing CAMS to be the superior approach. Primary outcome measures are suicidal ideation and suicide attempts, with secondary outcome measures including general symptoms of mental health problems. Changes in the outcome measures are compared between the two groups from baseline to 6 and 12 months after patients are included in the study. The study has the potential to impact the science of treating suicidal individuals and it could benefit the general public by establishing CAMS as an effective clinical approach for rapidly reducing suicide risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 8, 2016
CompletedFirst Posted
Study publicly available on registry
February 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedApril 19, 2021
April 1, 2021
4 years
February 8, 2016
April 13, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in scores on Beck's Scale for Suicide Ideation (BSSI)
Interview scale with 19 items that measures a patient's suicidal ideation at its worst point in the past 2 weeks.
From baseline to 6 and 12 months after patient is included in the study
Secondary Outcomes (3)
Changes in scores on The Outcome Questionaire 45 (OQ-45)
From baseline to 6 and 12 months after patient is included in the study
Norwegian Patient Registry (NPR) data
Yearly for five years after study inclusion
Changes in scores on Suicide Attempt Self-Injury Count (SASI-C)
changes from baseline to 6 and 12 months after patient is included in the study
Study Arms (2)
CAMS treatment
EXPERIMENTALPsychotherapy using the Collaborative Assessment and Management of Suicidality framework
Treatment as usual
ACTIVE COMPARATOROrdinary treatment for suicidal patients
Interventions
Eligibility Criteria
You may qualify if:
- Significant suicide ideation on Beck's Scale for Suicide Ideation (score 13 and above). Informed consent to participate.
You may not qualify if:
- Active psychosis, cognitive or physical impairment or other problems that preclude the ability to understand the study procedures and provide informed consent, non-Norwegian speaking subjects
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vestre Viken Hospital Trustlead
- The Catholic University of Americacollaborator
- Helse Sor-Ostcollaborator
- Norwegian Institute of Public Healthcollaborator
Study Sites (1)
Vestre Viken Helseforetak
Drammen, 3004, Norway
Related Publications (3)
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
PMID: 33884617DERIVEDStorebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.
PMID: 32368793DERIVEDRyberg W, Fosse R, Zahl PH, Brorson I, Moller P, Landro NI, Jobes D. Collaborative Assessment and Management of Suicidality (CAMS) compared to treatment as usual (TAU) for suicidal patients: study protocol for a randomized controlled trial. Trials. 2016 Oct 3;17(1):481. doi: 10.1186/s13063-016-1602-z.
PMID: 27716298DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roar Fosse, Ph.D.
Division of mental health and addiction, Vestre Viken
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2016
First Posted
February 19, 2016
Study Start
April 1, 2015
Primary Completion
April 1, 2019
Study Completion
October 1, 2019
Last Updated
April 19, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be shared/ published